Pre-treatment naive T cells are associated with severe irAE following PD-1/CTLA4 checkpoint blockade for melanoma
Kathryne E. Marks, Alice Horisberger, Mehreen Elahee, Ifeoluwakiisi Adejoorin, Nilasha Ghosh, Michael Andrew Postow, Laura T. Donlin, Anne R. Bass, Deepak A. Rao
This study identifies pre-treatment naive CD4+ T cell abundance as a predictor of severe irAEs in patients receiving anti-PD-1/CTLA4 checkpoint inhibitor therapy for melanoma.
JCI Insight · Nov 25, 2025Peer-reviewedImmunology